Pharmacogenetics of Statin-Induced Myotoxicity

Frontiers in Genetics
Ping Siu KeeSimran D S Maggo

Abstract

Statins, a class of lipid-lowering medications, have been a keystone treatment in cardiovascular health. However, adverse effects associated with statin use impact patient adherence, leading to statin discontinuation. Statin-induced myotoxicity (SIM) is one of the most common adverse effects, prevalent across all ages, genders, and ethnicities. Although certain demographic cohorts carry a higher risk, the impaired quality of life attributed to SIM is significant. The pathogenesis of SIM remains to be fully elucidated, but it is clear that SIM is multifactorial. These factors include drug-drug interactions, renal or liver dysfunction, and genetics. Genetic-inferred risk for SIM was first reported by a landmark genome-wide association study, which reported a higher risk of SIM with a polymorphism in the SLCO1B1 gene. Since then, research associating genetic factors with SIM has expanded widely and has become one of the foci in the field of pharmacogenomics. This review provides an update on the genetic risk factors associated with SIM.

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Aug 27, 1981·The New England Journal of Medicine·M S Brown, J L Goldstein
Jul 14, 2000·Physiological Reviews·M Wyss, R Kaddurah-Daouk
Feb 17, 2001·Clinical Pharmacology and Therapeutics·C KyrklundP J Neuvonen
Oct 16, 2001·European Journal of Clinical Pharmacology·M IgelK von Bergmann
Dec 26, 2001·Clinical Pharmacology and Therapeutics·A B MulderI Vermes
Jan 25, 2002·Current Controlled Trials in Cardiovascular Medicine·Curt D Furberg, Bertram Pitt
Apr 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomayant PrueksaritanontThomas A Baillie
Jun 18, 2002·Journal of Cellular and Molecular Medicine·C Stancu, A Sima
Jul 9, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A AsbergH Holdaas
Jul 27, 2002·Journal of the American College of Cardiology·Richard C PasternakUNKNOWN National Heart, Lung and Blood Institute
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Paul D ThompsonRichard H Karas
Jul 10, 2003·British Journal of Clinical Pharmacology·Thomayant PrueksaritanontNathan Yu
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ronald W Estabrook
Nov 25, 2003·FEBS Letters·Geoffrey Chang
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Jessica MwinyiThomas Gerloff
Jun 17, 2004·Circulation·Stefano BellostaAlberto Corsini
Nov 24, 2004·Pharmaceutical Research·Chihiro KondoYuichi Sugiyama
Jan 22, 2005·Fundamental & Clinical Pharmacology·Michael Schachter
May 19, 2005·Pharmacogenetics and Genomics·Russell A WilkeJames K Burmester
May 21, 2005·Toxicologic Pathology·F Russell WestwoodRobert C Scott
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Edmund LeeDennis Schneck
Dec 14, 2005·Archives of Internal Medicine·Karen E HansenJames H Stein

❮ Previous
Next ❯

Citations

Jan 20, 2021·Future Cardiology·Vishnu Priya Pulipati, Michael H Davidson
Feb 17, 2021·Current Opinion in Lipidology·Joana Rita Chora, Mafalda Bourbon
Jul 2, 2021·Pharmacogenomics·Charles A Brunette, Jason L Vassy
Aug 18, 2021·Pharmacological Reports : PR·Carolina Dagli-HernandezRosario Dominguez Crespo Hirata

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

PRagmatic Continuum Indicator Summary 2 ( PRECIS
GATM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Northwest Dentistry
William E Stein
Northwest Dentistry
Patrick M Lloyd
Academic Medicine : Journal of the Association of American Medical Colleges
Lyuba KonopasekEdward Krupat
© 2021 Meta ULC. All rights reserved